Complement activation by vascular prostheses and its role in progression of arteriosclerotic lesions

M Miyauchi1, S Shionoya

  • 1First Department of Surgery, Nagoya University School of Medicine, Japan.

Angiology
|October 1, 1988
PubMed

Insights

Vascular prostheses like bovine grafts, dacron, and PTFE activate the complement system, with bovine grafts causing the most activation. Complement levels are elevated in arterial diseases and correlate with lipids in arteriosclerosis obliterans.

Area of Science:

  • Immunology
  • Vascular Surgery
  • Biomaterials Science

Background:

  • The complement system plays a crucial role in immune responses and inflammation.
  • Vascular prostheses are essential in treating arterial diseases, but their interaction with the immune system is not fully understood.
  • Previous research suggests potential inflammatory responses to biomaterials used in vascular grafts.

Purpose of the Study:

  • To investigate whether vascular prostheses activate the complement system.
  • To determine the degree and pathway of complement activation by different vascular prostheses.
  • To explore the relationship between complement levels, arterial diseases, and serum lipids.

Main Methods:

  • In vitro and in vivo assays including C3a, C4a, and C5a measurement.
  • Crossed immunoelectrophoresis to analyze complement activation pathways.
  • Measurement of complement levels (C3, C4, CH50) in patients with various arterial diseases.
  • Correlation analysis of complement levels with serum lipids in arteriosclerosis obliterans (ASO) patients.

Main Results:

  • Bovine graft, dacron, and PTFE vascular prostheses were found to activate the complement system in vitro.
  • Complement activation varied by material: bovine graft > dacron > PTFE.
  • Elevated C3 and C4 levels were observed in patients with acute arterial occlusion.
  • Healthy elderly individuals exhibited higher C3 and C4 levels than younger healthy adults.
  • A positive correlation was found between C3 levels and serum lipid levels in ASO patients.

Conclusions:

  • Vascular prostheses, particularly bovine grafts, activate the complement system, suggesting a potential inflammatory mechanism.
  • Complement system activation by prostheses may be relevant to the progression of arteriosclerotic changes.
  • Further assessment of vascular prostheses should consider their complement-activating properties.

Related Concept Videos

Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...